ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025
Translation and cultural adaptation of tools to assess diverse Asian American and Asian Canadian subgroups: The Asian Cohort for Alzheimer's Disease (ACAD) Study.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The Canadian multi-ethnic research on aging (CAMERA) study: Design, participant characteristics, and preliminary findings.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Observational
- Translation and cultural adaptation of tools to assess diverse Asian American and Asian Canadian subgroups: The Asian Cohort for Alzheimer's Disease (ACAD) Study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
- Understanding dementia in Filipino Americans: risk factors, research gaps, and the role of community-based participatory research.Alzheimer's & dementia (New York, N. Y.)Article
- Protocol for the Asian Cohort for Alzheimer's Disease (ACAD) Study.Alzheimer's & dementia (New York, N. Y.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
Abstract
introductionThe availability of sociocultural and language-appropriate study materials and instruments is critical for the assessment of cognitive function in people from diverse backgrounds. This report describes the translations and cultural adaptations of study materials for the Asian Cohort for Alzheimer's Disease (ACAD) study.
methodsWe performed translations and cultural adaptations in accordance with the World Health Organization (WHO) translation guidelines to ensure reliable, complete, and culturally appropriate translations from English to the specified Asian languages.
resultsWe developed Asian language versions of the ACAD documents (consent, data collection packet, and community and social media outreach materials) reflecting the sociocultural backgrounds of the ACAD target population (i.e., older Asian adults) DISCUSSION: The multistep translation process accounting for distinctive Asian sociocultural and language backgrounds provides an important guideline for Alzheimer's disease and related dementias (ADRD) researchers to promote health literacy and research with underrepresented Asian American and Canadian adults. HIGHLIGHTS: Asian American and Asian Canadian older adults are the fastest-growing populations. A lack of linguistically and culturally appropriate cognitive assessment tools creates barriers for quality healthcare and clinical research. We report the translations and cultural adaptations of the Asian Cohort for Alzheimer's Disease (ACAD) study materials into Chinese, Korean, and Vietnamese. This translation methodology should be extended to Asian Indians, Filipinos, and other Asian American or Asian Canadian populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.